Journal of Pharmaceutical Innovation最新文献

筛选
英文 中文
Phytochemical Profiling and Bioactive Potential of Lagochilus seravschanicus: Antioxidant, Anti-Diabetic, Anti-Hemolytic, Cytotoxicity, Phytotoxicity and Antimicrobial Activities 蛇腿草的植物化学特征和生物活性潜力:抗氧化、抗糖尿病、抗溶血、细胞毒性、植物毒性和抗菌活性
IF 2.6 4区 医学
Journal of Pharmaceutical Innovation Pub Date : 2026-10-12 DOI: 10.1007/s12247-026-10741-5
Sanam Ashraf, Zubaria Tul Ain, Sampath Chinnam, Javed Iqbal, Banzeer Ahsan Abbasi, Sobia Kanwal, Ghulam Murtaza, Mohsin Kazi, Tariq Mahmood
{"title":"Phytochemical Profiling and Bioactive Potential of Lagochilus seravschanicus: Antioxidant, Anti-Diabetic, Anti-Hemolytic, Cytotoxicity, Phytotoxicity and Antimicrobial Activities","authors":"Sanam Ashraf,&nbsp;Zubaria Tul Ain,&nbsp;Sampath Chinnam,&nbsp;Javed Iqbal,&nbsp;Banzeer Ahsan Abbasi,&nbsp;Sobia Kanwal,&nbsp;Ghulam Murtaza,&nbsp;Mohsin Kazi,&nbsp;Tariq Mahmood","doi":"10.1007/s12247-026-10741-5","DOIUrl":"10.1007/s12247-026-10741-5","url":null,"abstract":"<div><p>Scientists are researching the therapeutic potential of herbal plants, which frequently leads to the identification of novel plants and bioactive chemicals that can be used in the development of new drugs. Natural phytochemicals are non-toxic, and their medicinal properties keep them in demand as alternative treatments for a variety of ailments. This motivated many researchers to explore plants in order to find bioactive compounds with significant pharmacological activities. Therefore, this research was performed to compare phytochemical profiling and biological activity of chloroform and methanolic extracts of roots, leaves, and flowers of the <i>Lagochilus seravschanicus</i> plant growing in Gilgit-Baltistan, Pakistan. Phytochemical screening showed the existence of 21 secondary metabolites and over fourteen functional groups of the FT-IR spectroscopy in all extracts of the plant. The quantitative analysis exhibited the maximum phenolic (76.24 ± 0.01 GAE mg/g) and flavonoid (74.53 ± 0.01 GAE mg/g) content in methanolic leaf extracts. Methanolic flower extract (LSFM) displayed the antioxidant capacity of (83.32 ± 0.50 mg AAE/g), followed by leaf methanolic extract (LSLM) that displayed moderate cytotoxicity against HeLa cells with an IC<sub>50</sub> value of 278 µg/mL. The leaf methanolic extract (LSLM) also exhibited significant anti-diabetic capacity (51.94%) by α-amylase inhibition and the high anti-hemolytic capacity of (90.24 ± 0.58%) on the human red blood cells. Moderate phytotoxicity was observed in leaf extracts (15%), lowering the germination of radish seeds. The findings showed that <i>L. seravschanicus</i> extracts displayed resistance against every bacterial and fungal strain. The maximum inhibitory zone was displayed by LSLM (18 ± 0.5 mm) against <i>E. faecalis</i>,<i> B. subtilis</i>,<i> B. atrophaeus</i>,<i> and S. aureus.</i> For antifungal activity, the highest ZOI exhibited by chloroform leaf extract (LSLC) against <i>A. fumigatus</i> and <i>A. niger</i> (17 ± 0.5 mm ZOI). These results suggest that <i>L. seravschanicus</i> has bioactive compounds possessing antioxidant, anticancer, antimicrobial, and enzyme-inhibitory potential and can serve as a source of pharmacological agents in the future.</p></div>","PeriodicalId":656,"journal":{"name":"Journal of Pharmaceutical Innovation","volume":"22 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149189063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Injectable and Photocrosslinked Methacrylate Gelatin/ Pluronic F127 Diacrylate Hydrogel Enhanced Articular Cartilage Regeneration in Osteoarthritis 可注射和光交联的甲基丙烯酸酯明胶/ Pluronic F127二丙烯酸酯水凝胶增强骨关节炎关节软骨再生
IF 2.6 4区 医学
Journal of Pharmaceutical Innovation Pub Date : 2026-10-12 DOI: 10.1007/s12247-026-11063-2
Zhen-wei Li, Guan-sheng Han, Chen Shao, De-gui Xu, Tian-chen Yao, Zheng-lin Hu
{"title":"Injectable and Photocrosslinked Methacrylate Gelatin/ Pluronic F127 Diacrylate Hydrogel Enhanced Articular Cartilage Regeneration in Osteoarthritis","authors":"Zhen-wei Li,&nbsp;Guan-sheng Han,&nbsp;Chen Shao,&nbsp;De-gui Xu,&nbsp;Tian-chen Yao,&nbsp;Zheng-lin Hu","doi":"10.1007/s12247-026-11063-2","DOIUrl":"10.1007/s12247-026-11063-2","url":null,"abstract":"<div><p>Osteoarthritis (OA) is a degenerative condition marked by the deterioration of articular cartilage, usually linked to mechanical joint damage. MMPs play a crucial role in the cartilage degradation observed in OA patients. This study developed an injectable hydrogel (IHG) composed of a mechanically resilient, reverse-thermo-sensitive F127DA (FD) and an MMP-responsive, thermo-sensitive gelatin methacryloyl (GM). The IHG was engineered to deliver TGF-β and KG with precise control via temperature manipulation. The hydrophobic properties of FD and hydrophilic properties of GM provide effective intra-articular distribution of various drugs, thereby enhancing their therapeutic efficacy. In situ photocrosslinking of the IHG occludes cartilage damage and inhibits deterioration. The overexpression of MMP in the OA milieu induces TGF-β release, attracting bone marrow mesenchymal stromal cells (BMDSCs), and mechanical stress from the joint actions liberates KG, alleviating inflammation and facilitating chondrogenic differentiation. The proposed IHG, responsive to mechanical stress and the osteoarthritic micromilieu, can improve OA cartilage regeneration. This methodology exhibits considerable promise for progressing osteoarthritic cartilage engineering.</p></div>","PeriodicalId":656,"journal":{"name":"Journal of Pharmaceutical Innovation","volume":"22 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149189408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Magnetic Nanoparticles for Theranostic Nanomedicine: A Novel Barrier-Route-Stimulus Design Framework, Complexity-Translatability Heuristic and Translational Evidence in Seven Disease Contexts 磁性纳米粒子用于治疗纳米医学:一种新的屏障-路径-刺激设计框架,复杂性-可译性启发式和七种疾病背景下的转化证据
IF 2.6 4区 医学
Journal of Pharmaceutical Innovation Pub Date : 2026-10-12 DOI: 10.1007/s12247-026-11073-0
Rupak Sarkar, Kundan Singh Bora, Hitesh Kumar Dewangan
{"title":"Magnetic Nanoparticles for Theranostic Nanomedicine: A Novel Barrier-Route-Stimulus Design Framework, Complexity-Translatability Heuristic and Translational Evidence in Seven Disease Contexts","authors":"Rupak Sarkar,&nbsp;Kundan Singh Bora,&nbsp;Hitesh Kumar Dewangan","doi":"10.1007/s12247-026-11073-0","DOIUrl":"10.1007/s12247-026-11073-0","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;p&gt;Magnetic Nanoparticles (MNPs), of which Superparamagnetic iron oxide nanoparticles (SPIONs) are the most clinically mature subclass, represent a class of cutting-edge theranostic platforms in that they simultaneously integrate drug delivery and AMF-hyperthermia alongside live MR imaging. Although SPIONs (magnetite/maghemite) are used as the base focus here, the performance of cobalt ferrites, permalloy alloys, and gadolinium-doped variants in context as the defining boundaries between material-specific design rules is presented here. Non-selective biodistribution and systemic toxicity plagued traditional pharmacotherapy, which SPIONs fundamentally countered through their favourable but context-dependent biocompatibility that requires careful evaluation of lysosomal iron release, ferroptotic risk, and route-dependent toxicity, tunable surface chemistry, and magnetically guided precision.Magnetic Nanoparticles (MNPs), of which Superparamagnetic iron oxide nanoparticles (SPIONs) are the most clinically mature subclass, represent a class of cutting-edge theranostic platforms in that they simultaneously integrate drug delivery and AMF-hyperthermia alongside live MR imaging. Although SPIONs (magnetite/maghemite) are used as the base focus here, the performance of cobalt ferrites, permalloy alloys, and gadolinium-doped variants in context as the defining boundaries between material-specific design rules is presented here. Non-selective biodistribution and systemic toxicity plagued traditional pharmacotherapy, which SPIONs fundamentally countered through their favourable but context-dependent biocompatibility that requires careful evaluation of lysosomal iron release, ferroptotic risk, and route-dependent toxicity, tunable surface chemistry, and magnetically guided precision.&lt;/p&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;p&gt;This review strongly determines the translational landscape and mechanistics of nanomagnetic formulations across seven important disease areas such as oncology (lung, breast, prostate, and glioblastoma), Neurodegenerative (Alzheimer's disease, Parkinson's disease), pulmonary arterial hypertension, diabetes mellitus, tuberculosis, and asthma by using passive (EPR-mediated) and active targeting strategies, stimulus-responsive drug release paradigms, blood–brain barrier penetration mechanisms.&lt;/p&gt;&lt;h3&gt;Method&lt;/h3&gt;&lt;p&gt;This narrative review summarizes exemplary preclinical formulation candidates and registered clinical trials conducted for the proposed seven areas for the purpose of creating conceptual designs that include the CE-marked EU medical device NanoTherm® for glioblastoma thermotherapy.&lt;/p&gt;&lt;h3&gt;Result&lt;/h3&gt;&lt;p&gt;A novel unified magnetic nanoformulation design logic tree is demonstrated, providing ideas related to formulation selection around an anatomical barrier–route–stimulus triad, and it argues for a conceptual complexity-translatability heuristic: where clinically successful systems seem to be ones with simpler formulations. AMF-b","PeriodicalId":656,"journal":{"name":"Journal of Pharmaceutical Innovation","volume":"22 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149189062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Palbociclib Letrozole Loaded Liquid Crystaline Nanoparticles for Treatment of Breast Cancer : Design, Optimization, In-Vitro Evaluation and In-Vivo Characterization 帕博西尼来曲唑负载液晶纳米颗粒治疗乳腺癌:设计,优化,体外评价和体内表征
IF 2.6 4区 医学
Journal of Pharmaceutical Innovation Pub Date : 2026-10-12 DOI: 10.1007/s12247-026-11118-4
Umesh B. Kolap, Himmat Singh Chawra, Sunil T. Galatage
{"title":"Palbociclib Letrozole Loaded Liquid Crystaline Nanoparticles for Treatment of Breast Cancer : Design, Optimization, In-Vitro Evaluation and In-Vivo Characterization","authors":"Umesh B. Kolap,&nbsp;Himmat Singh Chawra,&nbsp;Sunil T. Galatage","doi":"10.1007/s12247-026-11118-4","DOIUrl":"10.1007/s12247-026-11118-4","url":null,"abstract":"<div><p>Current research work aimed to develop and characterise of liquid crystalline nanoparticles (LCNPs) physically blended dual-LCNP formulation with palbociclib (PCB) and letrozole (LTZ) to improve therapeutic performance in treatment of breast cancer. Drug-loaded LCNPs were prepared using glyceryl monooleate (GMO) as the lipid phase and Poloxamer-407 as the stabilizer via a high-energy emulsification followed by probe sonication. A 3² full factorial design was applied to systematically optimize critical formulation variables affecting particle size and entrapment efficiency. The optimized LCNs of dispersions were combined to obtain the final formulation (PLNs-9) and characterized for morphology (TEM), thermal behaviour (DSC), crystallinity (XRD), and drug–excipient compatibility (FTIR). The PLNs-9 exhibited nanoscale particle size (144.2 ± 5.3 nm) with high entrapment efficiencies (PCB 95.54 ± 3.57%, LTZ 84.35 ± 2.86%). Solid-state analyses confirmed molecular dispersion of drugs within the lipid matrix. In vitro release studies demonstrated sustained drug release under physiological conditions. Cytotoxicity studies in MCF-7 breast cancer cells revealed significantly enhanced antiproliferative activity of PLNs-9 (IC₅₀ = 10.56 ± 1.34 µg; <i>p</i> &lt; 0.001) compared with individual drugs and their physical combination, accompanied by increased apoptotic cell populations and pronounced G2/M phase arrest. Pharmacokinetic evaluation demonstrated prolonged systemic circulation and approximately 2-fold enhancement in relative bioavailability compared to both PCB and LTZ. These findings suggest that the developed PLNs-9 containing PCB and LTZ combination represents a promising synergistic nanotherapeutic platform for breast cancer management.</p></div>","PeriodicalId":656,"journal":{"name":"Journal of Pharmaceutical Innovation","volume":"22 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149189414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Silico Identification and Mechanistic Characterization of Cyanobacterial Metabolites as Potential CD38 Inhibitors for Multiple Myeloma 蓝藻代谢物作为多发性骨髓瘤潜在CD38抑制剂的硅鉴定和机制表征
IF 2.6 4区 医学
Journal of Pharmaceutical Innovation Pub Date : 2026-10-12 DOI: 10.1007/s12247-026-11102-y
Xiaoyi Dun, Shuang Chen, Qinfen Wu
{"title":"In Silico Identification and Mechanistic Characterization of Cyanobacterial Metabolites as Potential CD38 Inhibitors for Multiple Myeloma","authors":"Xiaoyi Dun,&nbsp;Shuang Chen,&nbsp;Qinfen Wu","doi":"10.1007/s12247-026-11102-y","DOIUrl":"10.1007/s12247-026-11102-y","url":null,"abstract":"<div><p>Multiple myeloma (MM) is an incurable plasma cell malignancy characterized by dysregulation of CD38, a multifunctional ectoenzyme and receptor critical for tumor progression and immune modulation. While monoclonal antibodies targeting CD38 have improved clinical outcomes, small-molecule inhibitors remain scarce, limiting alternative therapeutic strategies. In this study, we employed a comprehensive in silico approach to identify drug-like, non-toxic marine Cyanobacterial metabolites as promising potential CD38 inhibitors. A total of 1085 MM-associated genes were intersected with 357 CD38-interacting genes to identify 207 MM-associated targets, which were enriched in immune-regulatory pathways. The CD38 binding pocket was characterized, and molecular docking screened Cyanobacterial metabolites for binding affinity and drug-likeness, identifying top candidates compliant with Lipinski, Ghose, Veber, Egan, and Muegge rules. Based on binding affinity, the selected drug-like, non-toxic metabolites (CyanoMetDB_1359, CyanoMetDB_2811, and CyanoMetDB_2812) exhibited favorable interactions with key residues, including TRP125, LEU145, TRP176, and THR221, overlapping with co-crystallized ligand interactions. Molecular dynamics simulations over 200 ns revealed stable protein-ligand complexes, with consistent RMSD, RMSF, Rg, SASA, distance, and hydrogen-bond profiles. Extensive principal component analysis and free energy landscapes confirmed conformational stability and minimal fluctuation. MM-PBSA calculations indicated favorable binding free energies, with residue-based decomposition suggesting critical stabilizing interactions. Collectively, this study identifies rare, marine-derived small-molecule candidates capable of effectively targeting CD38, bridging marine natural product chemistry with MM therapeutics. These findings provide a foundation for future experimental validation and development of small-molecule CD38 inhibitors derived from natural sources, with potential anti-myeloma activity.</p></div>","PeriodicalId":656,"journal":{"name":"Journal of Pharmaceutical Innovation","volume":"22 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149189415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Co-delivery of Quercetin and Resveratrol via Polymeric Nanoparticles for Enhanced Therapeutic Efficacy Against Colorectal Cancer 槲皮素和白藜芦醇通过聚合物纳米颗粒共同递送增强对结直肠癌的治疗效果
IF 2.6 4区 医学
Journal of Pharmaceutical Innovation Pub Date : 2026-10-10 DOI: 10.1007/s12247-026-11100-0
Kumar Janakiraman, Vaidevi Sethuraman, Geethanjali Sampath, Venkateshwaran Krishnaswami
{"title":"Co-delivery of Quercetin and Resveratrol via Polymeric Nanoparticles for Enhanced Therapeutic Efficacy Against Colorectal Cancer","authors":"Kumar Janakiraman,&nbsp;Vaidevi Sethuraman,&nbsp;Geethanjali Sampath,&nbsp;Venkateshwaran Krishnaswami","doi":"10.1007/s12247-026-11100-0","DOIUrl":"10.1007/s12247-026-11100-0","url":null,"abstract":"<div><h3>Background</h3><p>Colorectal cancer (CRC) remains a major global health burden, emphasizing the need for targeted therapies with improved efficacy and fewer adverse effects. Quercetin and resveratrol possess substantial anticancer activity, but their therapeutic application is limited by poor bioavailability, instability, and rapid degradation.</p><h3>Methods</h3><p>Quercetin- and resveratrol-co-loaded polymeric nanoparticles (QRNPs) were formulated using poly(lactic-co-glycolic acid) (PLGA) and D-α-tocopheryl polyethylene glycol succinate (TPGS). The optimized formulation was evaluated for particle size, zeta potential, encapsulation efficiency, morphology, drug–polymer compatibility, pH-dependent drug release, gastrointestinal stability, cellular uptake, cytotoxicity, and apoptosis in Caco-2 colorectal cancer cells.</p><h3>Results</h3><p>Optimized QRNPs showed a particle size of 174–177 nm, zeta potential of approximately −22 to −24 mV, and encapsulation efficiency above 80%. FTIR analysis confirmed drug–polymer compatibility, while HR-TEM revealed uniform spherical morphology. Drug-release studies demonstrated minimal release at pH 7.4 and increased release at pH 5.5, indicating preferential release under acidic tumor-like conditions. QRNPs also remained stable in simulated gastrointestinal fluids, demonstrating formulation robustness. Compared with free quercetin and resveratrol, QRNPs produced greater cytotoxicity, with CC<sub>50</sub> values of 48.84 μg/mL at 24 h and 32.75 μg/mL at 48 h. Fluorescence imaging demonstrated enhanced cellular uptake, and Annexin V-FITC analysis confirmed increased apoptosis in treated cells.</p><h3>Conclusion</h3><p>PLGA–TPGS-based quercetin–resveratrol nanoparticles improved drug stability, cellular uptake, pH-responsive release, gastrointestinal robustness, and in-vitro anticancer activity. These findings support their potential as a promising nanocarrier system for improving colorectal cancer therapy through efficient co delivery of quercetin and resveratrol, while potentially reducing limitations of free drugs.</p><h3>Graphical Abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":656,"journal":{"name":"Journal of Pharmaceutical Innovation","volume":"22 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149189406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Design, Characterization, and Evaluation of a Thermogelling Intranasal Delivery System of Rasagiline Mesylate for Brain Targeting 甲磺酸雷沙吉兰脑靶向热凝胶鼻内给药系统的设计、表征和评价
IF 2.6 4区 医学
Journal of Pharmaceutical Innovation Pub Date : 2026-10-10 DOI: 10.1007/s12247-026-11104-w
Dumpa Rushi Kumar Reddy, Suryaprakash Reddy Chappidi
{"title":"Design, Characterization, and Evaluation of a Thermogelling Intranasal Delivery System of Rasagiline Mesylate for Brain Targeting","authors":"Dumpa Rushi Kumar Reddy,&nbsp;Suryaprakash Reddy Chappidi","doi":"10.1007/s12247-026-11104-w","DOIUrl":"10.1007/s12247-026-11104-w","url":null,"abstract":"<div><h3>Background</h3><p>Parkinson’s Disease is the second most common neurodegenerative disorder worldwide. Although levodopa and monoamine oxidase-B (MAO-B) inhibitors remain the cornerstone of symptomatic management, oral administration is often limited by poor brain targeting and restricted penetration across the blood–brain barrier. The present study aimed to develop and optimize a thermoresponsive nasal in situ gel of Rasagiline Mesylate (RM) to facilitate direct nose-to-brain delivery.</p><h3>Materials and Methods</h3><p>A Central Composite Design (CCD) was employed to optimize the formulation. Poloxamer 407 (A: 15–30%, including axial points of 11.89 and 33.11%) and dodecyl maltoside (B: 1.0–2.0%, including axial points of 0.79 and 2.21%) were selected as independent variables, while gelation time, mucoadhesive strength, and permeation coefficient were considered response variables. The developed formulations were characterized for gelation time, mucoadhesive strength, drug content, pH, gelation temperature, viscosity, in vitro permeation, droplet size distribution, and plume geometry.</p><h3>Results</h3><p>The optimized formulation (RM1; 22.5% Poloxamer 407 and 1.5% dodecyl maltoside) demonstrated rapid thermogelation at physiological temperature (30.21 s), favourable mucoadhesive strength (~ 1615.8 dyne/cm²), and an enhanced permeation coefficient (0.0029 cm/s). In contrast, formulations containing higher polymer concentrations (RM10; 30% Poloxamer 407 and 2% dodecyl maltoside) exhibited prolonged gelation and reduced permeation performance. All formulations maintained a pH of approximately 7.3, indicating suitability for nasal administration. The optimized gel also exhibited acceptable spray characteristics, viscosity, and drug content uniformity.</p><h3>Conclusion</h3><p>The optimized thermosensitive nasal in situ gel of rasagiline mesylate demonstrated desirable physicochemical properties, mucoadhesion, and permeation behaviour, supporting its potential as a non-invasive nose-to-brain delivery platform. This approach may enhance central nervous system targeting of MAO-B inhibitors and represents a promising strategy for improving therapeutic outcomes in Parkinson’s disease.</p></div>","PeriodicalId":656,"journal":{"name":"Journal of Pharmaceutical Innovation","volume":"22 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149188897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liraglutide as a Novel Strategy for Improving Metabolic and Hormonal Profiles in Obese Women with Polycystic Ovary Syndrome 利拉鲁肽作为改善肥胖多囊卵巢综合征妇女代谢和激素谱的新策略
IF 2.6 4区 医学
Journal of Pharmaceutical Innovation Pub Date : 2026-10-10 DOI: 10.1007/s12247-026-10995-z
Sara Medhat Georgy, Nada Farag Elnaidany, Nora A Abdelmoneum, Sara Abdallah Mohamed Salem, Heba F. Salem, Rania M. Sarhan
{"title":"Liraglutide as a Novel Strategy for Improving Metabolic and Hormonal Profiles in Obese Women with Polycystic Ovary Syndrome","authors":"Sara Medhat Georgy,&nbsp;Nada Farag Elnaidany,&nbsp;Nora A Abdelmoneum,&nbsp;Sara Abdallah Mohamed Salem,&nbsp;Heba F. Salem,&nbsp;Rania M. Sarhan","doi":"10.1007/s12247-026-10995-z","DOIUrl":"10.1007/s12247-026-10995-z","url":null,"abstract":"<div><h3>Purpose</h3><p>This study aimed to investigate the effect of liraglutide and metformin as monotherapies on the hormonal, metabolic and clinical parameters of Poly Cystic Ovary Syndrome (PCOS). Participants were assigned to receive either Liraglutide (gradually titrated up to 3.0 mg/day as tolerated), Metformin (1000 mg/day), or standard lifestyle modification as a control group for 6 months.</p><h3>Methods</h3><p>A randomized, parallel, clinical trial was conducted on 150 patients (50 per group) who completed the study, out of 183 initially randomized patients diagnosed with PCOS.</p><h3>Results</h3><p>Out of 183 randomized patients, 150 completed the 24-week protocol (n = 50 per group). Most baseline characteristics were comparable across groups. Following 24 weeks of treatment, baseline-adjusted linear regression demonstrated that liraglutide induced significantly greater weight reduction compared to control (adjusted mean difference: -10.13 kg, FDR-adjusted p &lt; 0.001). Furthermore, liraglutide yielded substantial improvements in insulin resistance, as evidenced by a significantly lower HOMA-IR compared to control (adjusted mean difference: -0.58, FDR-adjusted p &lt; 0.001). Menstrual cycle regularity markedly improved in the liraglutide group (76.0%) compared to metformin (50.0%) and control (32.0%) (p &lt; 0.001). Clinical pregnancy rates were 29.0% Control, 65.7% Liraglutide, 52.9% Metformin; overall between-group difference remained significant after FDR correction (χ²=9.026, FDR-adjusted p=0.044). Nausea, heartburn, and constipation were more frequent with liraglutide than metformin.</p><h3>Conclusion</h3><p>Liraglutide is significantly more effective than metformin in improving body weight, glycemic control, and menstrual frequency in women with PCOS and metabolic dysfunction. These findings support liraglutide as a primary therapeutic approach, particularly in obesity-associated PCOS. It was registered at ClinicalTrials.gov under the identifier NCT05965908, registered on July 20, 2023.</p></div>","PeriodicalId":656,"journal":{"name":"Journal of Pharmaceutical Innovation","volume":"22 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149188896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hydrophilic DNA Conjugation in HPMC Films: A Strategy for Poorly Soluble Drugs HPMC膜中的亲水性DNA偶联:一种用于难溶性药物的策略
IF 2.6 4区 医学
Journal of Pharmaceutical Innovation Pub Date : 2026-10-10 DOI: 10.1007/s12247-026-11121-9
Debashis Purohit, Amit Kumar Nayak, Mahendra Kumar Sahu, Aakanksha Sinha, Prince Kumar Jha
{"title":"Hydrophilic DNA Conjugation in HPMC Films: A Strategy for Poorly Soluble Drugs","authors":"Debashis Purohit,&nbsp;Amit Kumar Nayak,&nbsp;Mahendra Kumar Sahu,&nbsp;Aakanksha Sinha,&nbsp;Prince Kumar Jha","doi":"10.1007/s12247-026-11121-9","DOIUrl":"10.1007/s12247-026-11121-9","url":null,"abstract":"<div><p>The study examined the effect of DNA conjugation on the solubility of a drug in an HPMC polymeric film. The study found that incorporating DNA extract in the film improved drug solubility. The formulation NHE5, with 20% bioplasticizer, showed better drug release compared to other formulations. FTIR and DSC and XRD analyses were carried out. This study indicates that a promising development in drug delivery technology is DNA conjugation to HPMC polymeric films. DNA-HPMC conjugates can enhance DNA-functionalized polymers, promizing improved drug delivery systems and maximizing therapeutic efficacy in pharmaceutical formulations.</p><h3>Graphical Abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":656,"journal":{"name":"Journal of Pharmaceutical Innovation","volume":"22 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149188895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thermo-Responsive Hydrogels Loaded with Holothuria atra Silver–Chitosan Nanocomposites for Burn Wound Healing: A Network Pharmacology-Guided Study 负载银壳聚糖纳米复合材料的热响应水凝胶用于烧伤创面愈合:网络药理学指导的研究
IF 2.6 4区 医学
Journal of Pharmaceutical Innovation Pub Date : 2026-10-10 DOI: 10.1007/s12247-026-11107-7
Basant A. Abou-Taleb, Zeinab M. Awwad, Dina S. Ghallab
{"title":"Thermo-Responsive Hydrogels Loaded with Holothuria atra Silver–Chitosan Nanocomposites for Burn Wound Healing: A Network Pharmacology-Guided Study","authors":"Basant A. Abou-Taleb,&nbsp;Zeinab M. Awwad,&nbsp;Dina S. Ghallab","doi":"10.1007/s12247-026-11107-7","DOIUrl":"10.1007/s12247-026-11107-7","url":null,"abstract":"<div><h3>Purpose</h3><p>Wound healing remains a major clinical challenge, particularly in conditions characterized by excessive inflammation and impaired angiogenesis. To address this, the present study was designed to develop and evaluate biocompatible, eco-friendly nano-gels that modulate inflammation and enhance vascularization to accelerate tissue repair.</p><h3>Methods</h3><p>Three <i>Holothuria atra</i> extract-loaded nano-systems, chitosan nanoparticles (CS NPs), silver nanoparticles (Ag NPs), and chitosan-coated silver nanoparticles (CS-Ag NPs), were green-synthesized, incorporated into a thermo-responsive poloxamer 407/sodium hyaluronate in situ gel, and evaluated for wound-healing efficacy. Network pharmacology was applied to systematically decipher the multi-target mechanisms of <i>H. atra</i> bioactives and guide biomarker selection.</p><h3>Results</h3><p>Network pharmacology identified <i>MAPK1</i>, <i>IL6</i>, <i>AKT1</i>, <i>TNF</i>, and <i>VEGFA</i> as central hub genes prominently enriched in the MAPK, PI3K-Akt, TNF-α, and VEGF signaling pathways, highlighting the multi-target mechanism of <i>H. atra</i> bioactives. Physicochemical characterization demonstrated an optimal gelling temperature (32–34 °C), rapid gelation time (50–55 s), skin-compatible pH (5.8–6.2), and pseudoplastic rheological behavior. In vitro release studies confirmed sustained drug release from the nano-gel formulations compared to the unformulated extract solution, with the CS-Ag NP gel exhibiting superior controlled-release performance. In a Sprague-Dawley rat burn model, the nano-gel formulations significantly accelerated wound closure; the <i>H. atra</i>-CS-Ag NP gel achieved a leading wound contraction of 71.72 ± 2.5% by day 12, comparable to the commercial standard HYALO<sup>®</sup> 4 Control (70.18 ± 2.9%). Biochemical analysis revealed significant downregulation of pro-inflammatory cytokines (TNF-α and IL-6) alongside elevated expression of angiogenic and repair markers (VEGFA, AKT1, and MAPK1). Furthermore, in vitro–in vivo correlation (IVIVC) analysis demonstrated strong linear relationships between in vitro dissolution efficiency and network pharmacology-guided biomarkers (r² ≥ 0.922, <i>p</i> ≤ 0.05), confirming a novel systems-level therapeutic approach.</p><h3>Conclusion</h3><p>Overall, integrating marine-derived bioactives, silver-chitosan nanotechnology, and thermo-responsive hydrogels offers a promising synergistic platform for advanced wound therapy.</p></div>","PeriodicalId":656,"journal":{"name":"Journal of Pharmaceutical Innovation","volume":"22 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149188894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书